Researchers at the University of Colorado Boulder have discovered a chemical compound capable of working with natural bodily processes to break through antibiotic resistant bacteria and have published the results in the journal PLOS Pathogens.
Although attentions for many scientists have... Read More »
The top Democrat on the Senate Homeland Security and Governmental Affairs Committee, U.S. Sen. Gary Peters (D-MI), announced a pending examination of the Trump Administration’s planning, coordination, and execution of preparation and response efforts to the COVID-19 pandemic.
This... Read More »
Under the Expanding COVID-19 Testing Capacity Act, introduced this week by U.S. Sen. Elizabeth Warren (D-MA), the federal government would be required to manufacture and expand the number of institutions to which it distributes diagnostic tests to increase access to free COVID-19 testing.
Based... Read More »
The federal government announced Wednesday that it would purchase an additional 100 million doses of the Pfizer/BioNTech COVID-19 vaccine to be delivered next year.
Coordinated through the U.S. Departments of Health and Human Services (HHS) and Defense (DoD), Pfizer will have to meet several... Read More »
The U.S. Food and Drug Administration (FDA) approved a treatment for the Zaire Ebolavirus infection in adults and children.
The treatment is called Ebanga, a human monoclonal antibody that blocks the virus's binding to the cell receptor, thus preventing its entry into the cell.
Zaire... Read More »
A group of U.S. Senators is commending the Department of Homeland Security (DHS) and Homeland Security Investigations (HSI) for their efforts to protect against counterfeit vaccines and personal protective equipment through Operation Stolen Promise 2.0.
“In April U.S. Immigration and Customs... Read More »
In the wake of an Immigration and Customs Enforcement (ICE) Homeland Security Investigations (HSI) probe, the U.S. Attorney’s Office for the District of Maryland seized two fraudulent COVID-19 websites.
The domain names, mordernatx.com and regeneronmedicals.com, purported to be the websites of... Read More »
As the COVID-19 pandemic drags on, the National Institutes of Health (NIH) has awarded more than $107 million to support new, non-traditional means of plugging gaps in COVID-19 testing and surveillance, as well as to develop platforms for future outbreaks.
The awards were given under a program... Read More »
Congress passed a $900 billion pandemic relief package Monday, which includes legislation that will provide more than $73 billion to the Department of Health and Human Services (HHS) for federal response efforts.
While much attention has been put on the $600 direct stimulus payment and $300 per... Read More »
On behalf of 190 participating economies, the global COVAX initiative has secured access to nearly 2 billion COVID-19 vaccine candidates and plans to begin dispensing those doses early next year to protect vulnerable groups.
While most of the vaccine candidates involved are still under... Read More »
The Defense Advanced Research Projects Agency (DARPA) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) have earmarked $37.6 million for COVID-19 treatment development.
A research team representing scientists from The Wistar Institute,... Read More »
Thanks to an expansion of a partnership with the Biomedical Advanced Research and Development Authority (BARDA), Hologic, Inc. will accelerate the development of the Aptima SARS-CoV-2/Flu assay, dangling the promise of a test capable of differentiating between the pair.
Specifically, the test... Read More »
A Moderna, Inc. vaccine is on track to become the second COVID-19 vaccine approved for emergency use in the United States, following this week's positive endorsement from the Vaccines and Related Biological Products Advisory Committee (VRBPAC).
The VRBPAC, an advisory committee for the U.S. Food... Read More »
Researchers at Rensselaer Polytechnic Institute are looking to improve the manufacturing of rapidly deployed structures to address future shortages of medical care and quarantine facilities during a health crisis, like the current pandemic.
The stress that COVID-19 has placed on medical... Read More »
World Health Organization (WHO) personnel and officials representing Sanofi, one of the world’s leading pharmaceutical companies, said the entities are partnering to readdress neglected tropical diseases (NTDs).
“This decades-long collaboration exemplifies a successful public–private... Read More »
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Abbott this week for its BinaxNOW COVID-19 Ag Card Home Test, allowing for virtually guided use by anyone 15 years or older, with a prescription.
Healthcare providers will refer such patients to the... Read More »
Bavarian Nordic A/S secured $83 million in funding from the Biomedical Advanced Research and Development Authority (BARDA) this week, marking a second investment into its JYNNEOS smallpox vaccine from the U.S. government.
This follows a $106 million investment into the vaccine made in April,... Read More »
A Phase 1/2 clinical study is getting underway in the United Kingdom for Valneva SE’s vaccine candidate against the SARS-CoV-2 virus responsible for COVID-19.
The French pharmaceutical company said on Wednesday that the VLA2001-201 study is a randomized, double-blind trial to evaluate the... Read More »
The Johns Hopkins Center for Health Security at the Bloomberg School of Public Health has launched a coalition to promote equitable vaccination distribution.
The COVID-19 pandemic has disproportionally affected communities of color in the country. Infection and mortality rates are highest in... Read More »
The U.S. Centers for Disease Control and Prevention (CDC) will award $140 million for COVID-19 vaccine preparedness, the Department of Health and Human Services (HHS) announced.
The CDC will also award almost $87 million for tracking and testing to 64 jurisdictions, including all 50 states and... Read More »
Three entities have initiated real-world testing efforts to determine the most effective measures to address the public transit virus spread reduction.
The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) has partnered with the New York Metropolitan... Read More »
The U.S. Food and Drug Administration (FDA) has issued the first-ever emergency use authorization (EUA) for an over-the-counter, at-home test for COVID-19, awarding that honor to the rapid Ellume COVID-19 Home Test.
This means anyone at least two years of age or older, whether displaying... Read More »
The U.S. Departments of Health and Human Services (HHS) and Defense (DoD) have partnered with the non-profit Quantum Leap Healthcare Collaborative on a phase 2 clinical trial to screen multiple potential COVID-19 drugs simultaneously.
Unlike many such trials, which focus on a single drug, this... Read More »
A bipartisan bill authorizing a public advocacy campaign to promote COVID-19 vaccine participation and provide science-backed information was introduced in the House this week.
The bill provides necessary funds for the Department of Health and Human Services and the Centers for Disease Control... Read More »
Tel Aviv University (TAU) researchers maintain the coronavirus can be killed efficiently, quickly, and cheaply using ultraviolet (UV) light-emitting diodes (UV-LEDs).
Scientists believe the UV-LED technology would soon be available for private and commercial use, suggesting installation in air... Read More »
Although distribution of the Pfizer COVID-19 vaccine has begun in the United States, Democrats are criticizing reports that the White House failed to pre-order more doses of the vaccine when it had the opportunity and are pressing for more transparent pandemic planning.
News broke last week in... Read More »
In documents released ahead of a vaccine advisory committee meeting on Dec. 17 to discuss the future of Moderna’s COVID-19 vaccine, the U.S. Food and Drug Administration (FDA) determined the two-dose vaccine to be effective and safe for adults.
If approved for emergency use authorization later... Read More »
A COVID-19 vaccine candidate from Sanofi and GSK ran into trouble last week when interim results from a phase 1/2 study showed it to produce little immune response among older adults.
While the candidate showed sufficient results in those aged 18 to 49 years, researchers believe its lack of... Read More »
With the distribution of Pfizer’s COVID-19 vaccine underway in the United States and an emergency use authorization (EUA) expected to follow for Moderna’s vaccine this week, the federal government is preparing through massive logistics and additional purchases.
The government’s Operation... Read More »
A delegation of Maine lawmakers said they are seeking insight from the Department of Health and Human Services (HHS) regarding transparency and communication with state partners on COVID-19 vaccine distribution.
Sens. Susan Collins (R-ME) and Angus King (I-ME) recently joined Reps. Chellie... Read More »
U.S. Reps. John Larson (D-CT) and Joe Courtney (D-CT) recently introduced the Pandemic Supplies Production Act designed to nationalize the production and distribution of supplies deemed essential to fighting the COVID-19 pandemic.
“As we fight through this second surge of COVID-19, we need to... Read More »
The U.S. Food and Drug Administration (FDA) is preparing to quickly authorize the Pfizer Inc.-BioNTech COVID-19 vaccine for emergency use, following an advisory committee's recommendations.
That committee voted 17 to 4 in favor of approval. Once emergency use authorization (EUA) is granted, the... Read More »
Roche has formed a partnership with Moderna to use its Elecsys Anti-SARS-CoV-2 S, or COVID-19, antibody test in Moderna’s mRNA-1273 vaccine research trials.
The Roche tests will provide a quantitative measurement of SARS-CoV-2 antibodies and help to establish a correlation between... Read More »
The National Institutes of Health (NIH) has awarded a $2 million R01 grant to a Virginia Tech research team to develop a single-dose Zika virus vaccine candidate.
"This grant focuses on a new strategy that we developed to produce safe and effective flavivirus vaccines," Jonathan Auguste, an... Read More »
Those in need of a COVID-19 test may no longer need to leave the privacy of their homes, even to gather a prescription for it, with news of authorization granted by the United States Food and Drug Administration to the LabCorp Pixel COVID-19 Test Home Collection Kit.
The first no prescription... Read More »